Atish Patel

Atish Patel

Auto-generated profile, based on publicly available information

Atish Patel

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2012 in Chinese Journal of Cancer
Verified
Journal Article
Open access
KSKamlesh Sodani
Kamlesh Sodani
APAtish Patel
Atish Patel
RKRishil J. Kathawala
Rishil J. Kathawala
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
Multidrug resistance proteins (MRPs) are members of the C family of a group of proteins named ATP-binding cassette (ABC) transporters. These ABC transporters together form the largest branch of proteins within the human body. The MRP family comprises of 13 members, of which MRP1 to MRP9 are the major transporters indicated to cause multidrug resistance in tumor cells by extruding anticancer drugs out of the cell. They are mainly lipophilic anionic transporters and are reported to transport free or conjugates of glutathione (GSH), glucuronate, or sulphate. In addition, MRP1 to MRP3 can transport neutral organic drugs in free form in the presence of free GSH. Collectively, MRPs can transport drugs that differ structurally and mechanistically, including natural anticancer drugs, nucleoside analogs, antimetabolites, and tyrosine kinase inhibitors. Many of these MRPs transport physiologically important anions such as leukotriene C4, bilirubin glucuronide, and cyclic nucleotides. This review focuses mainly on the physiological functions, cellular resistance characteristics, and probable in vivo role of MRP1 to MRP9.

5 February 2012 in Chinese Journal of Cancer
Verified
Journal Article
Open access
YSYue-Li Sun
Yue-Li Sun
APAtish Patel
Atish Patel
PKPriyank Kumar
Priyank Kumar
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
Multidrug resistance (MDR) in cancer cells can significantly attenuate the response to chemotherapy and increase the likelihood of mortality. The major mechanism involved in conferring MDR is the overexpression of ATP-binding cassette (ABC) transporters, which can increase efflux of drugs from cancer cells, thereby decreasing intracellular drug concentration. Modulators of ABC transporters have the potential to augment the efficacy of anticancer drugs. This editorial highlights some major findings related to ABC transporters and current strategies to overcome MDR.

1 January 2013 in Cancer Letters
Verified
Journal Article
Closed access
ATAmit K Tiwari
Amit K Tiwari
KSKamlesh Sodani
Kamlesh Sodani
CDChun-Ling Dai
Chun-Ling Dai
AAAlaa H. Abuznait
Alaa H. Abuznait
SSSatyakam Singh
Satyakam Singh
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

1 June 2012 in Biochemical Pharmacology
Verified
Journal Article
Closed access
KSKamlesh Sodani
Kamlesh Sodani
ATAmit K Tiwari
Amit K Tiwari
SSSatyakam Singh
Satyakam Singh
APAtish Patel
Atish Patel
ZXZhi-Jie Xiao
Zhi-Jie Xiao
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

1 August 2014 in Biochemical Pharmacology
Verified
Journal Article
Closed access
YWYi-Jun Wang
Yi-Jun Wang
RKRishil J. Kathawala
Rishil J. Kathawala
YZYun-Kai Zhang
Yun-Kai Zhang
APAtish Patel
Atish Patel
PKPriyank Kumar
Priyank Kumar
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

24 November 2014 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
HZHui Zhang
Hui Zhang
APAtish Patel
Atish Patel
SMShao‐Lin Ma
Shao‐Lin Ma
XLXiao Jie Li
Xiao Jie Li
YZYun‐Kai Zhang
Yun‐Kai Zhang
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen